We are the first to report two individuals with heterozygous LIMK1 missense variants, showing divergent clinical phenotypes, ranging from epileptic encephalopathy to immunodeficiency, and glucose regulation issues. This evidence concerns the gene LIMK1 and Epileptic encephalopathy.